Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Bioinformatics Platform Market Set to Witness Robust Growth, Projected to reach US$ 14.0 billion by 2029, Growing at a CAGR of 14.7% from 2019 to 2029

This image opens in the lightbox

News provided by

Prophecy Market Insights

10 May, 2023, 12:03 GMT

Share this article

Share toX

Share this article

Share toX

According to Prophecy Market Insights "Bioinformatics Platform Market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to register a CAGR of 14.7%"

COVINA, Calif., May 10, 2023 /PRNewswire/ -- What is a Bioinformatics Platform?

Bioinformatics is the effective use of biological data and application of computer technology. Large volumes of big data are developed in post-genomics era from full genomic sequencing, proteomics, structural genomics, and micro-array.

Growing demand for personalized medicine and rising biotechnology and research & development expenditure has become major contribution in market growth. New product launch and growing strategic partnerships has further, facilitated Bioinformatics Platform market growth.

What is Prophecy's Analyst View on Bioinformatics Platform Market?

Growing funding for bioinformatics from public and private sector has become a key factor in target market growth. Technological advancement, decreased cost in sequencing, presence of major key players and growing number of genomic research activities is expected to fuel the demand for Bioinformatics Platform market growth in coming years.

Who are the Top Key players operating in the Bioinformatics Platform Market?

  • Illumina Inc.
  • Sophia Genetics
  • Qiagen
  • Dassault Systems
  • ID Business Solutions
  • Agilent Technologies
  • Genologics Life Sciences Software Inc.
  • DNASTAR
  • Wuxi NextCODE
  • BGI

Looking for More Information? Download the Free Sample Report: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4343

Report Scope:

Attribute

Details

The base year for estimation

2022

Forecast period

2023 – 2032

Market representation

Revenue in USD Million & CAGR from 2022 – 2032

Accounted in 2019

US$ 3.6 billion

Estimated to be in 2029

US$ 14.0 billion

CAGR 

14.7 %

Market Segmentation

By Platform Type- Sequence Analysis Platform, Sequence Alignment Platform, Structural & Functional Analysis Platforms, and Others

By Application– Drug Development, Molecular Genomics, Gene Therapy, Personalized Medicines, and Others

By End-user– Academic & Research Institutes, Contract Research Organizations, and Biotechnology Organizations

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Customization Scope

Avail of customized purchase options to meet your exact research needs.

https://www.prophecymarketinsights.com/market_insight/Insight/request-customization/4343

What are the Recent News of Bioinformatics Platform Market?

  • In February 2023, BioSkryb launched new commercial platform at Advances in Genome Biology and Technology (AGBT) 2023 General Meeting. New launched platform was "ResolveOME" Whole Genome and Transcriptome Amplification System and "BaseJumper" Bioinformatics Platform which offers dynamic and simple visualization of multiomic findings.
  • In March 2022, ARUP launched new bioinformatics platform "Rio" for faster and better next-generation sequencing test results. New launched "Rio" platform is the world-class bioinformatics and analytics platform which provides rock-solid foundation.

What are the Drivers of the Bioinformatics Platform Market?

  • Rising demand for personalized medicine
  • Emergence of Next-Generation Sequencing (NGS) technology
  • Increasing use of big data analytics in life sciences
  • Growing applications in drug discovery and development
  • Advancements in artificial intelligence (AI) and machine learning (ML)
  • Increasing application in agricultural research

What are the Restrains of the Bioinformatics Platform Market?

  • Complexity of biological data
  • Lack of standardization in data formats and protocols
  • High cost of bioinformatics platforms
  • Data security and privacy concerns
  • Lack of skilled professionals

What are the Opportunities in the Bioinformatics Platform Market?

  • Cloud-based platforms
  • Blockchain technology
  • Advancements in AI and ML
  • Precision medicine
  • Genomics research
  • Agricultural research

What are the Covid-19 Scenario on Bioinformatics Platform Market?

  • Increased Demand for COVID-19 Testing: The COVID-19 pandemic has led to an increased demand for COVID-19 testing, which has resulted in the development and adoption of bioinformatics platforms for analyzing and interpreting COVID-19 related data.
  • Accelerated Drug Development: The COVID-19 pandemic has accelerated the development of drugs and vaccines, which has led to an increased demand for bioinformatics platforms for drug discovery and development
  • Increased Use of Telemedicine: The COVID-19 pandemic has led to an increased use of telemedicine, which has resulted in the adoption of bioinformatics platforms for remote patient monitoring, data analysis, and interpretation.
  • Disrupted Supply Chain: The COVID-19 pandemic has disrupted the supply chain of bioinformatics platforms, leading to delays in product development and distribution.
  • Increased Focus on Genomic Sequencing: The COVID-19 pandemic has increased the focus on genomic sequencing, which has led to the development and adoption of bioinformatics platforms for analyzing and interpreting genomic data related to COVID-19.

Looking for More Information? Download the PDF Brochure Report:

https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/4343

Conclusion:

In conclusion, the Bioinformatics Platform Market is a rapidly growing industry that is driven by factors such as increasing demand for personalized medicine, advancements in genomics research, and the growing availability of biological data. The market is also facing challenges related to data complexity, lack of standardization, and a shortage of skilled professionals.

However, the adoption of cloud-based platforms, advancements in AI and ML, and the integration of blockchain technology offer significant growth opportunities for the industry. The COVID-19 pandemic has also impacted the market, accelerating the demand for bioinformatics platforms for COVID-19 related data analysis and drug development.

Overall, the Bioinformatics Platform Market is expected to continue to grow in the coming years, driven by advancements in technology, increasing demand for genomic data analysis, and the growing need for personalized medicine.

Key questions answered in this report:

  • What are the current and future trends in the Bioinformatics Platform Market?
  • What are the major drivers and restraints affecting the growth of the Bioinformatics Platform Market?
  • What are the opportunities and challenges in the Bioinformatics Platform Market?
  • What is the market size and growth rate of the Bioinformatics Platform Market, and what factors are driving this growth?
  • Which bioinformatics platforms are currently dominating the market, and what is their competitive landscape?
  • What are the different applications of bioinformatics platforms, and how are they being used in various industries such as healthcare, agriculture, and biotechnology?
  • What are the key factors that are driving the adoption of cloud-based bioinformatics platforms, and what are the benefits of using such platforms?
  • How is the COVID-19 pandemic impacting the Bioinformatics Platform Market, and what are the future implications of this impact?

Report available for Immediate Download:

https://www.prophecymarketinsights.com/market_insight/buy_now/4343?licence=6350&report_type=+Bioinformatics+Platform+Market&v1_licence_type=press_id

Browse Other Related Research Reports from Prophecy Market Insights:

Bioinformatics market accounted for US$ 181.47 billion in 2020 and is estimated to be US$ 869.6 billion by 2030 and is anticipated to register a CAGR of 8.9%.

Biomarkers market accounted for US$ 47.02 billion in 2020 and is estimated to be US$ 161.78 billion by 2030 and is anticipated to register a CAGR of 13.1%.

Molecular Diagnostics Market accounted for US$ 15.23 billion in 2020 and is estimated to be US$ 45.30 billion by 2030 and is anticipated to register a CAGR of 11.5%

About Us:

Prophecy Market Insights is a leading provider of market research services, offering insightful and actionable reports to clients across various industries. With a team of experienced analysts and researchers, Prophecy Market Insights provides accurate and reliable market intelligence, helping businesses make informed decisions and stay ahead of the competition. The company's research reports cover a wide range of topics, including industry trends, market size, growth opportunities, competitive landscape, and more. Prophecy Market Insights is committed to delivering high-quality research services that help clients achieve their strategic goals and objectives.

To know more
Contact Us:
Sales
Prophecy Market Insights
📞 US toll free: +1 860 531 2574
📞 Rest of world: + 91 7775049802
✉ Email- sales@prophecymarketinsights.com
🌐 Website- www.prophecymarketinsights.com

Follow us on:
LinkedIn | Twitter | Facebook |Youtube 

Logo - https://mma.prnewswire.com/media/2067755/Prophecy_Market_Insights_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.